AdaptHealth Corp. (AHCO) 股票分析

公司概述

AdaptHealth Corp. primarily functions as a distributor of home medical equipment (HME), medical supplies, and related services within the United States market. The company operates across four distinct segments, specifically Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, to deliver comprehensive home healthcare solutions. This entity operates within the broader Healthcare sector and is classified under the Medical Devices industry, positioning it as a critical infrastructure provider for patients requiring home-based medical support. The company demonstrates significant scale with a market capitalization of $1.66B and an annual revenue of $3.24B, supported by a workforce of 10,900 employees. These financial figures indicate that AdaptHealth Corp. holds a substantial position in the domestic home medical equipment distribution landscape, reflecting a robust operational footprint capable of generating multi-billion dollar revenue streams despite the competitive nature of the medical device sector.

财务健康

The financial performance of AdaptHealth Corp. for the trailing twelve months (TTM) is characterized by a revenue of $3.24B, a net income of $-70,794,000, and an EBITDA of $586.49M. The substantial gap between the positive EBITDA of $586.49M and the negative net income of $-70,794,000 reveals a cost structure burdened by significant non-operating expenses or tax impacts that erode bottom-line profitability despite core operational earnings. The company maintains a free cash flow of $246.52M, which provides a critical buffer for financial flexibility, allowing the firm to service its obligations and potentially fund operational needs without relying solely on external financing. Profitability analysis shows a gross margin of 20.9%, an operating margin of 6.2%, and a profit margin of -2.2%, indicating that while the core sales model retains a portion of revenue, other costs or expenses are driving the final profit margin into negative territory. On the balance sheet, the company holds $106.24M in cash against $1.90B in total debt, resulting in a debt-to-equity ratio of 124.67, which signifies a highly leveraged financial structure where debt obligations significantly outweigh equity holdings. Liquidity is constrained by a current ratio of 1.02, suggesting that the company's current assets barely cover its current liabilities, pointing to tight short-term liquidity conditions that require careful cash management. Return metrics further illustrate operational challenges, with a return on equity of -4.3% and a return on assets of 2.9%, indicating that management effectiveness in generating shareholder value is currently negative relative to equity, while asset utilization yields a modest positive return.

估值评估

Valuation multiples for AdaptHealth Corp. present a mix of value and risk, with a trailing P/E ratio listed as N/A due to the negative net income, while the forward P/E is projected at 9.82. The disparity between the unavailable trailing P/E and the forward P/E of 9.82 implies that the market anticipates a future earnings trajectory that could turn the current losses into profitability, though this expectation carries inherent uncertainty given the current financial position. The price-to-book ratio stands at 1.07, indicating that the stock trades at a slight premium over its book value, suggesting investors are pricing in growth potential or asset quality beyond the historical accounting value. Alternative valuation metrics provide further context, with a price-to-sales ratio of 0.51 and an EV/EBITDA of 5.91, which collectively suggest the market is valuing the company based on its cash-generating ability (EBITDA) rather than current accounting earnings, a common approach for firms with negative net income. The stock's price range over the last year spans from a 52-week low of $7.11 to a 52-week high of $12.28, illustrating the volatility inherent in the company's trading environment. The beta value of 1.50 indicates that the stock's price volatility is significantly higher than the broader market, moving 50% more than the market index on average, which underscores the higher risk profile associated with investing in this specific healthcare subsector.

Growth & Income

Growth dynamics for AdaptHealth Corp. show a revenue growth rate of -1.2% year-over-year, while earnings growth is listed as N/A due to the company's current financial loss. The negative revenue growth combined with N/A earnings growth implies that the company is currently contracting in terms of top-line sales and has not yet achieved positive earnings growth to support dividend payments or aggressive reinvestment strategies. As a non-dividend payer, the company does not distribute a dividend yield or maintain a payout ratio, meaning that any retained earnings are theoretically available for reinvestment into operations or debt reduction rather than shareholder payouts. The overall growth and income profile for AdaptHealth Corp. is currently defined by a contraction in revenue and a lack of dividend income, reflecting a phase where the business may be focusing on market share retention or operational restructuring rather than expansion or income generation.